Longboard Pharmaceuticals, Inc. Common Stock
LBPH
LBPH was delisted on the 29th of November, 2024.
100 hedge funds and large institutions have $1.05B invested in Longboard Pharmaceuticals, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 49 increasing their positions, 27 reducing their positions, and 24 closing their positions.
400% more funds holding in top 10
Funds holding in top 10: 1 → 5 (+4)
81% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 27
28% more capital invested
Capital invested by funds: $820M → $1.05B (+$229M)
5% less funds holding
Funds holding: 105 → 100 (-5)
17% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 24
73% less call options, than puts
Call options by funds: $235K | Put options by funds: $878K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
+$13.4M |
| 2 |
BlackRock
New York
|
+$9.9M |
| 3 |
Pictet Asset Management
Carouge,
Switzerland
|
+$6.65M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$5.73M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$4.51M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$11.1M |
| 2 |
Millennium Management
New York
|
-$7.16M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$7.05M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6.78M |
| 5 |
AIC
AWM Investment Company
New York
|
-$4.57M |
LBPH Hedge Fund Activity: Q2 2024 in Review
100 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Longboard Pharmaceuticals, Inc. Common Stock (LBPH) for Q2 2024, worth a combined $1.05B — up 28% from $820M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of LBPH and 20 opened new positions — a net loss of 4 holders — while 27 trimmed existing stakes and 49 added.
The largest buyer was Viking Global Investors, adding an estimated $13.4M. The largest seller was Cormorant Asset Management, cutting an estimated $11.1M.
- 100 institutional investors held Longboard Pharmaceuticals, Inc. Common Stock (LBPH) as of Q2 2024, down from 105 in Q1 2024.
- Funds reported $1.05B of Longboard Pharmaceuticals, Inc. Common Stock stock for Q2 2024, up 28% quarter-over-quarter.
- 20 funds opened new Longboard Pharmaceuticals, Inc. Common Stock positions in Q2 2024 and 24 closed out, a net change of -4 holders.
- The largest Longboard Pharmaceuticals, Inc. Common Stock buyer in Q2 2024 was Viking Global Investors, an estimated $13.4M added.
- The largest Longboard Pharmaceuticals, Inc. Common Stock seller in Q2 2024 was Cormorant Asset Management, an estimated $11.1M sold.
Based on aggregated 13F filings for Q2 2024.